Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-08

Clinical Trial Update: Prediction of Recurrent Pregnancy Loss by a New Thrombophilia Based Genetic Risk Score

View source ↗

Summary

This clinical trial update reports completion of a study evaluating a thrombophilia-based genetic risk score to predict recurrent pregnancy loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ferrer inCode, S.L. | Conditions: Miscarriage, Recurrent | Status: COMPLETED